CSIMarket Company Name, Ticker, Customers, else..


Elanco Animal Health Inc  (ELAN)
Other Ticker:  
 

Elanco Animal Health Inc

ELAN's Fundamental analysis



Looking into Elanco Animal Health Inc growth rates, revenue grew by 12.02 % in II. Quarter 2024 from the same quarter a year ago. Ranking at No. 1431

Major Pharmaceutical Preparations industry recorded growth of revenues by 5.17 %

Elanco Animal Health Inc net loss decreased from $-97 millions, to $-50 millions in II. Quarter 2024,

• More on ELAN's Growth


Elanco Animal Health Inc
realized a net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 144.93 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.58.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.77.


• More on ELAN's Valuation
 
 Total Debt (Millions $) 5,676
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 483,011
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 4.8
 Tangible Book Value (Per Share $) -5.14

Elanco Animal Health Inc
realized net loss in trailing twelve months.

Company is currently trading with Price to Cash flow multiple of 144.93 in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.58.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.77.

Elanco Animal Health Inc Price to Book Ratio is at 1.2 lower than Industry Avg. of 85.07. and higher than S&P 500 Avg. of 0

• More on ELAN's Valuation

•  Market Capitalization (Millions $) 7,102
•  Shares Outstanding (Millions) 494
•  Employees 9,300
•  Revenues (TTM) (Millions $) 4,492
•  Net Income (TTM) (Millions $) -1,255
•  Cash Flow (TTM) (Millions $) 49
•  Capital Exp. (TTM) (Millions $) -198
•  Total Debt (Millions $) 5,676
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ 483,011
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 4.8
•  Tangible Book Value (Per Share $) -5.14

•  Market Capitalization (Millions $) 7,102
•  Shares Outstanding (Millions) 494
•  Employees 9,300
•  Revenues (TTM) (Millions $) 4,492
•  Net Income (TTM) (Millions $) -1,255
•  Cash Flow (TTM) (Millions $) 49
•  Capital Exp. (TTM) (Millions $) -198


    ELAN's Profitability Comparisons
Elanco Animal Health Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in II. Quarter 2024 to 2.96 % from 7.22 % in I. Quarter.




Profitability by Segment
Total 2.66 %



  Ratio
•   Capital Ratio (MRQ) 3.96
•  Total Debt to Equity (MRQ) 0.96
•  Tangible Leverage Ratio (MRQ) -
•  Asset Turnover Ratio (TTM) 0.32
•  Inventory Turnover Ratio (TTM) 1.21



Elanco Animal Health Inc faced margin deterioration, primarily through cost pressure. Operating Margin fell in II. Quarter 2024 to 2.96 % from 7.22 % in I. Quarter.



• More on ELAN's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com